Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2010 2
2011 1
2012 2
2014 1
2018 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
HLA-genotyping by next-generation-sequencing reveals shared and unique HLA alleles in two patients with coexisting neuromyelitis optica spectrum disorder and thymectomized myasthenia gravis: Immunological implications for mutual aetiopathogenesis?
Vakrakou A, Chatzistamatiou T, Koros C, Karathanasis D, Tentolouris-Piperas V, Tzanetakos D, Stathopoulos P, Koutsis G, Spyropoulou-Vlachou M, Evangelopoulos ME, Stefanis L, Stavropoulos-Giokas C, Anagnostouli M. Vakrakou A, et al. Among authors: spyropoulou vlachou m. Mult Scler Relat Disord. 2022 Jul;63:103858. doi: 10.1016/j.msard.2022.103858. Epub 2022 May 8. Mult Scler Relat Disord. 2022. PMID: 35594634
Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient's COVID-19 Infection.
Markoglou N, Simeakis G, Alevizaki M, Velonakis G, Chatzistamatiou T, Spyropoulou-Vlachou M, Stavropoulos-Giokas C, Stefanis L, Anagnostouli M. Markoglou N, et al. Among authors: spyropoulou vlachou m. Biomedicines. 2022 Nov 8;10(11):2850. doi: 10.3390/biomedicines10112850. Biomedicines. 2022. PMID: 36359367 Free PMC article.
Non-Inherited Maternal Antigens Identify Acceptable HLA Mismatches: A New Policy for the Hellenic Cord Blood Bank.
Panagouli E, Dinou A, Mallis P, Michalopoulos E, Papassavas A, Spyropoulou-Vlachou M, Meletis J, Angelopoulou M, Konstantopoulos K, Vassilakopoulos T, Stavropoulos-Giokas C. Panagouli E, et al. Among authors: spyropoulou vlachou m. Bioengineering (Basel). 2018 Sep 21;5(4):77. doi: 10.3390/bioengineering5040077. Bioengineering (Basel). 2018. PMID: 30248919 Free PMC article.
Natural killer (NK) cell receptors' repertoire in couples with recurrent spontaneous abortions.
Varla-Leftherioti M, Spyropoulou-Vlachou M, Niokou D, Keramitsoglou T, Darlamitsou A, Tsekoura C, Papadimitropoulos M, Lepage V, Balafoutas C, Stavropoulos-Giokas C. Varla-Leftherioti M, et al. Among authors: spyropoulou vlachou m. Am J Reprod Immunol. 2003 Mar;49(3):183-91. doi: 10.1034/j.1600-0897.2003.00018.x. Am J Reprod Immunol. 2003. PMID: 12797525
Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.
Gogas H, Dafni U, Koon H, Spyropoulou-Vlachou M, Metaxas Y, Buchbinder E, Pectasides E, Tsoutsos D, Polyzos A, Stratigos A, Markopoulos C, Panagiotou P, Fountzilas G, Castana O, Skarlos P, Atkins MB, Kirkwood JM. Gogas H, et al. Among authors: spyropoulou vlachou m. J Transl Med. 2010 Nov 3;8:108. doi: 10.1186/1479-5876-8-108. J Transl Med. 2010. PMID: 21044351 Free PMC article.
A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon.
Pancoska P, Kirkwood JM, Bouros S, Spyropoulou-Vlachou M, Pectasides E, Tsoutsos D, Polyzos A, Markopoulos C, Panagiotou P, Castana O, Bafaloukos D, Fountzilas G, Gogas H. Pancoska P, et al. Among authors: spyropoulou vlachou m. PLoS One. 2014 Jan 27;9(1):e86375. doi: 10.1371/journal.pone.0086375. eCollection 2014. PLoS One. 2014. PMID: 24475110 Free PMC article.
High frequency of human leukocyte antigen class II DRB1*1602 haplotype in Greek patients with myelodysplastic syndrome and of DRB1*1501 in the low-risk subgroup.
Kritikou-Griva E, Spyropoulou-Vlachou M, Tsagarakis NJ, Goumakou E, Vrani V, Galanopoulos A, Papadhimitriou SI, Androutsos G, Paterakis G, Stavropoulos-Giokas C. Kritikou-Griva E, et al. Among authors: spyropoulou vlachou m. Hum Immunol. 2012 Mar;73(3):278-81. doi: 10.1016/j.humimm.2011.12.013. Epub 2011 Dec 27. Hum Immunol. 2012. PMID: 22244918
12 results